Janney Capital Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-4,438
| Closed | -$414K | – | 246 |
|
|
2022
Q4 | $414K | Buy |
4,438
+1,411
| +47% | +$136K | 0.03% | 167 |
|
|
2022
Q3 | $289K | Buy |
+3,027
| New | +$300K | 0.02% | 177 |
|
|
2022
Q2 | – | Sell |
-2,105
| Closed | -$213K | – | 195 |
|
|
2022
Q1 | $213K | Sell |
2,105
-19,974
| -90% | -$2.1M | 0.02% | 195 |
|
|
2021
Q4 | $2.28M | Buy |
22,079
+416
| +2% | +$38.4K | 0.15% | 94 |
|
|
2021
Q3 | $1.84M | Sell |
21,663
-322
| -1% | -$27K | 0.12% | 101 |
|
|
2021
Q2 | $1.83M | Buy |
21,985
+582
| +3% | +$47.7K | 0.12% | 104 |
|
|
2021
Q1 | $1.61M | Sell |
21,403
-129,486
| -86% | -$9.43M | 0.11% | 107 |
|
|
2020
Q4 | $10.3M | Sell |
150,889
-13,056
| -8% | -$849K | 0.71% | 54 |
|
|
2020
Q3 | $9.57M | Sell |
163,945
-3,594
| -2% | -$224K | 0.65% | 65 |
|
|
2020
Q2 | $10.9M | Sell |
167,539
-2,722
| -2% | -$171K | 0.75% | 47 |
|
|
2020
Q1 | $10.1M | Sell |
170,261
-10,922
| -6% | -$729K | 0.77% | 43 |
|
|
2019
Q4 | $13.5M | Sell |
181,183
-3,642
| -2% | -$256K | 0.73% | 58 |
|
|
2019
Q3 | $11.7M | Sell |
184,825
-7,419
| -4% | -$440K | 0.65% | 64 |
|
|
2019
Q2 | $10.5M | Sell |
192,244
-10,200
| -5% | -$549K | 0.57% | 76 |
|
|
2019
Q1 | $10.9M | Sell |
202,444
-6,987
| -3% | -$431K | 0.57% | 71 |
|
|
2018
Q4 | $13.7M | Sell |
209,431
-18,891
| -8% | -$1.41M | 0.74% | 52 |
|
|
2018
Q3 | $18M | Sell |
228,322
-14,258
| -6% | -$1.02M | 0.78% | 48 |
|
|
2018
Q2 | $15.6M | Buy |
242,580
+39,932
| +20% | +$2.63M | 0.69% | 57 |
|
|
2018
Q1 | $12.6M | Buy |
202,648
+7,324
| +4% | +$525K | 0.55% | 77 |
|
|
2017
Q4 | $14.2M | Sell |
195,324
-16,105
| -8% | -$1.17M | 0.6% | 71 |
|
|
2017
Q3 | $17.2M | Sell |
211,429
-8,942
| -4% | -$707K | 0.74% | 52 |
|
|
2017
Q2 | $17.7M | Sell |
220,371
-7,489
| -3% | -$591K | 0.84% | 46 |
|
|
2017
Q1 | $17.9M | Sell |
227,860
-2,196
| -1% | -$175K | 0.83% | 45 |
|
|
2016
Q4 | $18.2M | Sell |
230,056
-11,653
| -5% | -$943K | 0.83% | 43 |
|
|
2016
Q3 | $21.5M | Sell |
241,709
-20,170
| -8% | -$1.9M | 0.97% | 39 |
|
|
2016
Q2 | $25.1M | Buy |
+261,879
| New | +$26.1M | 1.33% | 22 |
|
|
2016
Q1 | – | Sell |
-262,890
| Closed | -$25.7M | – | 158 |
|
|
2015
Q4 | $25.7M | Sell |
262,890
-257
| -0.1% | -$25.2K | 1.13% | 25 |
|
|
2015
Q3 | $25.4M | Buy |
263,147
+8,115
| +3% | +$853K | 1.15% | 27 |
|
|
2015
Q2 | $26.7M | Buy |
255,032
+2,078
| +0.8% | +$212K | 3.75% | 5 |
|
|
2015
Q1 | $26.1M | Buy |
252,954
+3,959
| +2% | +$401K | 0.87% | 32 |
|
|
2014
Q4 | $24M | Buy |
248,995
+13,538
| +6% | +$1.19M | 1.38% | 16 |
|
|
2014
Q3 | $18.7M | Buy |
235,457
+5,138
| +2% | +$405K | 1.13% | 25 |
|
|
2014
Q2 | $17.4M | Buy |
230,319
+11,824
| +5% | +$894K | 1.05% | 33 |
|
|
2014
Q1 | $16.4M | Buy |
218,495
+48,823
| +29% | +$3.45M | 1.09% | 34 |
|
|
2013
Q4 | $12.1M | Buy |
169,672
+8,614
| +5% | +$553K | 0.9% | 50 |
|
|
2013
Q3 | $9.14M | Buy |
161,058
+4,983
| +3% | +$297K | 0.75% | 64 |
|
|
2013
Q2 | $8.92M | Buy |
+156,075
| New | +$9.04M | 0.88% | 58 |
|
Other funds holding CVS
Janney Capital Management's CVS Position: Q1 2023 in Review
Janney Capital Management sold out of CVS Health (CVS) in Q1 2023, closing a stake of 4,438 shares — an estimated $414K sold.
Janney Capital Management first reported a position in CVS in Q2 2013 and held it in 37 quarters. The position peaked at $26.7M in Q2 2015. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.
- Janney Capital Management reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
- Janney Capital Management sold 4,438 CVS Health shares in Q1 2023, an estimated $414K.
- Janney Capital Management first reported a position in CVS Health in Q2 2013 and held it in 37 quarters.
- Janney Capital Management's CVS Health position peaked at $26.7M in Q2 2015.
- 2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.
Based on Janney Capital Management's 13F filing for Q1 2023, filed 28 Apr 2023.